- Scientists uncover how immune cells change in malaria-infected placentas
- Could help protect pregnant women and babies in high-risk areas
- Early research — not yet available as a treatment
This discovery may lead to better ways to fight malaria in pregnancy by targeting specific immune cell changes.
It starts with a fever. A pregnant woman in a rural clinic feels weak, dizzy. Her blood test shows malaria. She’s not alone. Every year, hundreds of thousands of pregnant women face this danger. Many don’t know the real threat isn’t just the fever — it’s what the infection does inside the placenta. It can starve the baby of nutrients, cause early birth, or worse. And current treatments don’t always prevent these hidden harms.
Now, scientists have found something new hiding in plain sight: a shift in a rare type of immune cell that could change how we fight this disease.
Malaria in pregnancy is a silent crisis. The Plasmodium falciparum parasite hides in the placenta, causing inflammation that harms both mother and baby. Over 100 million pregnancies are at risk each year in Africa alone. Even when women take preventive drugs, some still get infected. And once the placenta is involved, outcomes can be severe — low birth weight, stillbirth, or maternal anemia.
The immune system tries to respond. But in pregnancy, it’s a delicate balance. Too much attack, and the fetus is at risk. Too little, and the infection spreads. That’s why researchers are looking closely at immune cells called γδ T cells — rare but powerful regulators that act like first responders.
These cells can calm inflammation or ramp up defense. But until now, no one knew exactly how they change during placental malaria.
The surprising shift
For years, scientists thought γδ T cells mostly stayed the same during infection. But this study shows they don’t. They transform — and where they are in the body makes all the difference.
In healthy pregnancies, these cells are mostly in “ready mode,” waiting for signals. But in women with placental malaria, they shift into “attack mode.” Many become TEMRA cells — terminally differentiated effector memory cells — the kind that have seen battle and are primed to act fast.
But here’s the twist: this shift isn’t random. It’s guided by two immune messengers — IL-8 and IL-33 — that push these cells to mature faster.
What scientists didn’t expect
These cytokines were already known for their role in inflammation. But no one knew they could directly shape γδ T cell fate in pregnancy. The study found higher levels of IL-8 and IL-33 linked to more TEMRA cells in the mother’s blood — a sign the immune system is adapting to fight placental infection.
Think of it like a traffic control system. Cytokines are signals. γδ T cells are drivers. In a normal pregnancy, traffic flows smoothly. But when malaria hits, the signals change. IL-8 and IL-33 act like green lights, pushing immune cells to speed up their development and rush to the placenta.
And there’s more: these mature cells don’t just show up — they change how they fuel themselves.
Energy switch in action
Immune cells need energy to fight. Most young cells run on sugar (glycolysis), like a sprinter using quick bursts. But the mature γδ T cells in the mother’s blood switched to mitochondrial metabolism — like marathon runners burning fat for long endurance.
This metabolic reprogramming means these cells aren’t just activated — they’re built to last.
It’s like switching from a gas-powered scooter to a hybrid engine. The body is adapting for sustained defense.
The data behind the discovery
Researchers studied 50 women at delivery — 21 with placental malaria, 29 without. They collected blood from the mother, the placenta, and the umbilical cord. Then they mapped the types and states of γδ T cells in each spot.
They also measured levels of key cytokines and tested how immune cells used energy. In a subset of samples, they used a special test (SCENITH) to track metabolic activity after stimulation.
The results were clear: placental malaria changes both the identity and engine of γδ T cells — but only in specific locations.
Key findings revealed
In mothers with malaria, γδ T cells in the blood were more likely to be TEMRA — fully mature and ready to attack. This shift was linked to higher IL-8 and IL-33 levels.
At the same time, these cells showed signs of reduced exhaustion — lower levels of TIM-3 and PD-1, markers that usually mean the immune system is worn out. That’s a good sign. It suggests these cells are not just active, but functional.
This doesn’t mean this treatment is available yet.
But there’s a catch. The changes were not seen in cord blood. The baby’s immune cells stayed in “naïve” or early memory states. That means the mother’s immune adaptation doesn’t automatically protect the newborn.
That’s not the full story. The placenta itself showed a mix — some activated cells, but also signs of suppression. It’s a battlefield with both offense and defense.
A bigger picture emerging
Experts say this study fills a critical gap. We’ve long known placental malaria disrupts immunity. Now we see how — through cytokine signals and metabolic shifts that guide immune cell fate.
This isn’t just about malaria. It could help us understand other pregnancy infections or even autoimmune conditions where γδ T cells play a role.
If you’re pregnant in a malaria-prone area, this won’t change your care today. There are no new drugs or vaccines yet. But this research points to future options — possibly a way to boost the body’s natural defenses or design vaccines that train γδ T cells to respond better.
For now, prevention remains key: bed nets, antimalarial pills, and prenatal checkups.
Study limits to know
The study was small — only 50 women. And it looked at cells at one point in time: delivery. We don’t know how these changes unfold during pregnancy. Also, all tests were done in the lab — not in living animals or clinical trials.
What comes next
Scientists need to confirm if boosting IL-8 or IL-33 — or targeting metabolism — can actually protect against infection. Future studies may test drugs or vaccines that guide γδ T cells on purpose. But that could take years. Immune pathways are complex. One misstep could cause harm. So progress will be careful, step by step.
